Loading data
INKTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 5.76 m USD | 6.34 m USD | 15.49 m USD | 23.12 m USD | 13.97 m USD |
| Operating profit | -12.64 m USD | -11.29 m USD | -22.92 m USD | -30.95 m USD | -28.36 m USD |
| Interest expense | -110 k USD | -93 k USD | -28 k USD | — | — |
| Net income (reported basis) | -12.49 m USD | -10.78 m USD | -22.46 m USD | -27.99 m USD | -30.21 m USD |
| Basic earnings per share | -2.93 USD/share | -2.86 USD/share | -6.54 USD/share | -0.83 USD/share | -1.16 USD/share |
| Diluted earnings per share | -2.93 USD/share | -2.86 USD/share | -6.54 USD/share | -0.83 USD/share | -1.16 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.